Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewBone biology Open Access | 10.1172/jci.insight.198245

GALNT1 drives aggressive phenotypes of rheumatoid synoviocytes via NEK9 O‑glycosylation

Yaoyao Zou,1 Haobo Lin,1 Jianling Su,1 Jieying Wang,1 Qin Zeng,1 Tianxiao Feng,1 Yunxia Lei,1 Jianda Ma,2 Hudan Pan,3 Hanshi Xu,4 Lie Dai,1 and Yang Li5

1Department of Rheumatology and Immunology, Southern Medical University, Guangzhou, China

2Department of Rheumatology, Sun Yat-Sen University, Guangzhou, China

3State Key Laboratory of Traditional Chinese Medicine Syndrome, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

4Department of Rheumatology and Immunology, Sun Yat-Sen University, Guangzhou, China

5Department of Rheumatology and Immunology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

Find articles by Zou, Y. in: PubMed | Google Scholar

1Department of Rheumatology and Immunology, Southern Medical University, Guangzhou, China

2Department of Rheumatology, Sun Yat-Sen University, Guangzhou, China

3State Key Laboratory of Traditional Chinese Medicine Syndrome, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

4Department of Rheumatology and Immunology, Sun Yat-Sen University, Guangzhou, China

5Department of Rheumatology and Immunology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

Find articles by Lin, H. in: PubMed | Google Scholar

1Department of Rheumatology and Immunology, Southern Medical University, Guangzhou, China

2Department of Rheumatology, Sun Yat-Sen University, Guangzhou, China

3State Key Laboratory of Traditional Chinese Medicine Syndrome, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

4Department of Rheumatology and Immunology, Sun Yat-Sen University, Guangzhou, China

5Department of Rheumatology and Immunology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

Find articles by Su, J. in: PubMed | Google Scholar

1Department of Rheumatology and Immunology, Southern Medical University, Guangzhou, China

2Department of Rheumatology, Sun Yat-Sen University, Guangzhou, China

3State Key Laboratory of Traditional Chinese Medicine Syndrome, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

4Department of Rheumatology and Immunology, Sun Yat-Sen University, Guangzhou, China

5Department of Rheumatology and Immunology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

Find articles by Wang, J. in: PubMed | Google Scholar

1Department of Rheumatology and Immunology, Southern Medical University, Guangzhou, China

2Department of Rheumatology, Sun Yat-Sen University, Guangzhou, China

3State Key Laboratory of Traditional Chinese Medicine Syndrome, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

4Department of Rheumatology and Immunology, Sun Yat-Sen University, Guangzhou, China

5Department of Rheumatology and Immunology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

Find articles by Zeng, Q. in: PubMed | Google Scholar

1Department of Rheumatology and Immunology, Southern Medical University, Guangzhou, China

2Department of Rheumatology, Sun Yat-Sen University, Guangzhou, China

3State Key Laboratory of Traditional Chinese Medicine Syndrome, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

4Department of Rheumatology and Immunology, Sun Yat-Sen University, Guangzhou, China

5Department of Rheumatology and Immunology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

Find articles by Feng, T. in: PubMed | Google Scholar

1Department of Rheumatology and Immunology, Southern Medical University, Guangzhou, China

2Department of Rheumatology, Sun Yat-Sen University, Guangzhou, China

3State Key Laboratory of Traditional Chinese Medicine Syndrome, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

4Department of Rheumatology and Immunology, Sun Yat-Sen University, Guangzhou, China

5Department of Rheumatology and Immunology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

Find articles by Lei, Y. in: PubMed | Google Scholar

1Department of Rheumatology and Immunology, Southern Medical University, Guangzhou, China

2Department of Rheumatology, Sun Yat-Sen University, Guangzhou, China

3State Key Laboratory of Traditional Chinese Medicine Syndrome, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

4Department of Rheumatology and Immunology, Sun Yat-Sen University, Guangzhou, China

5Department of Rheumatology and Immunology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

Find articles by Ma, J. in: PubMed | Google Scholar

1Department of Rheumatology and Immunology, Southern Medical University, Guangzhou, China

2Department of Rheumatology, Sun Yat-Sen University, Guangzhou, China

3State Key Laboratory of Traditional Chinese Medicine Syndrome, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

4Department of Rheumatology and Immunology, Sun Yat-Sen University, Guangzhou, China

5Department of Rheumatology and Immunology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

Find articles by Pan, H. in: PubMed | Google Scholar

1Department of Rheumatology and Immunology, Southern Medical University, Guangzhou, China

2Department of Rheumatology, Sun Yat-Sen University, Guangzhou, China

3State Key Laboratory of Traditional Chinese Medicine Syndrome, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

4Department of Rheumatology and Immunology, Sun Yat-Sen University, Guangzhou, China

5Department of Rheumatology and Immunology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

Find articles by Xu, H. in: PubMed | Google Scholar

1Department of Rheumatology and Immunology, Southern Medical University, Guangzhou, China

2Department of Rheumatology, Sun Yat-Sen University, Guangzhou, China

3State Key Laboratory of Traditional Chinese Medicine Syndrome, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

4Department of Rheumatology and Immunology, Sun Yat-Sen University, Guangzhou, China

5Department of Rheumatology and Immunology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

Find articles by Dai, L. in: PubMed | Google Scholar

1Department of Rheumatology and Immunology, Southern Medical University, Guangzhou, China

2Department of Rheumatology, Sun Yat-Sen University, Guangzhou, China

3State Key Laboratory of Traditional Chinese Medicine Syndrome, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

4Department of Rheumatology and Immunology, Sun Yat-Sen University, Guangzhou, China

5Department of Rheumatology and Immunology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

Find articles by Li, Y. in: PubMed | Google Scholar

Published April 23, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.198245.
Copyright © 2026, Zou et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published April 23, 2026 - Version history
View PDF
Abstract

Fibroblast-like synoviocytes (FLSs) are crucial in driving synovial inflammation and joint damage in rheumatoid arthritis (RA). This study explored the functions and underlying mechanisms of GALNT1-mediated O-glycosylation, which is markedly upregulated in RA FLSs, in synovial aggression and subsequent experimental joint damage. Targeted suppression of GALNT1 effectively curtailed migration and invasion in RA FLSs and mitigated arthritis severity in a rat collagen-induced arthritis (CIA) model. Mechanistically, NEK9 was identified as a pivotal substrate and downstream effector of GALNT1, affecting the aggressive phenotype of RA FLSs. In vitro experiments further demonstrated that O-glycosylation of NEK9, mediated by GALNT1, promotes the pathogenic phenotype of RA FLSs by promoting cytoskeleton reorganization and restraining excessive endoplasmic reticulum (ER) stress activation. Our study provides mechanistic insights into the activation of RA FLSs and identifies GALNT1 as a potential therapeutic target for RA.

Graphical Abstract
graphical abstract
Supplemental material

View Unedited blot and gel images

View

Version history
  • Version 1 (April 23, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts